Načítá se...
Epigenetic pharmacotherapy for substance use disorder
Identifying novel therapeutics for the treatment of substance use disorder (SUD) is an area of intensive investigation. Prior strategies that have attempted to modify one or a few neurotransmitter receptors have had limited success, and currently there are no FDA-approved medications for the treatme...
Uloženo v:
| Vydáno v: | Biochem Pharmacol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733674/ https://ncbi.nlm.nih.gov/pubmed/31306644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2019.07.012 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|